Keyword: Massachusetts General Hospital
A new study suggests that some gut immune cells modulate the process by which the body either stores ingested food as fat or uses it for energy.
Scientists have early evidence that Amgen's oncolytic virus plus PD-1 and MEK inhibitors could be effective in treating melanoma.
The FDA cleared XenoTherapeutics to begin the first human clinical trial that uses live skin cells derived from pigs as a burn treatment.
Blocking the interaction between pathological tau proteins and the nuclear membrane of neurons could represent a new approach to Alzheimer's, a new study finds.
A tool called “polygenic risk scoring” could help physicians identify who faces a high risk of serious diseases.
A rare cell type, discovered by two teams and named as "pulmonary ionocyte," appears to help drive cystic fibrosis.
Scientists discovered that TB vaccine BCG restores blood sugar to near-normal levels for as long as five years by changing a key metabolic process.
A Harvard-led research team has identified a brain protein that exacerbates memory loss with age or PTSD.
The hospital network achieved the jump in scale by turning to outside backers including Eli Lilly, which collectively pumped $66 million into the fund.
A multipronged immune attack that includes CAR-T treatments may be needed to fight glioblastoma, Penn scientists suggest.
